Prognostic value of inflammatory markers (notably cytokines and procalcitonin), nutritional assessment, and organ function in patients with sepsis

European Cytokine Network

Volumn 21, Issue 1, 2010, Pages 19-26

  Suárez Santamaría, Marta ^a   Santolaria, Francisco ^a   Pérez Ramírez, Alina ^a   Alemán Valls, María Remedios ^a   Martínez Riera, Antonio ^a   González Reimers, Emilio ^a   De La Vega, María José ^a   Milena, Antonio ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

IL 10; IL 6; Mortality; Procalcitonin; Sepsis

Indexed keywords

CD14 ANTIGEN; CYTOKINE; FERRITIN; INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; LACTATE DEHYDROGENASE; LACTIC ACID; LIPOPOLYSACCHARIDE BINDING PROTEIN; PROCALCITONIN; TRANSFERRIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BACTEREMIA; BODY HEIGHT; BODY WEIGHT; CARDIOVASCULAR FUNCTION; CENTRAL NERVOUS SYSTEM FUNCTION; COMORBIDITY; CONTROLLED STUDY; FEMALE; GLASGOW COMA SCALE; GRIP STRENGTH; HOSPITAL PATIENT; HUMAN; INFLAMMATION; KIDNEY FUNCTION; LACTATE BLOOD LEVEL; LIVER FUNCTION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MORTALITY; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; SCORING SYSTEM; SEPSIS; TRANSFERRIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CALCITONIN; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; NUTRITION ASSESSMENT; ORGAN SPECIFICITY; PROGNOSIS; PROTEIN PRECURSORS; SEPSIS; SPAIN; YOUNG ADULT;

EID: 77149174519     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2009.0185     Document Type: Article

References (47)

1. Bone RC. The pathogenesis of sepsis. Ann Intern Med 1991; 115: 45769.
2. Bone RC. Toward an epidemiology and natural history of SIRS. JAMA 1992; 268: 3452-5.
3. Vincent JL, Mercan D. Dear Sirs, what is your PCT? Intensive Care Med 2000; 26: 1170-1.
4. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ ACCP/ATS/SIS International sepsis definitions conference. Crit Care Med 2003; 31: 1250-6.
5. Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 2004; 8: R234-42.
6. Müller B, Becker KL, Schächinger H, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000; 28: 977-83.
7. Harbarth S, Holeckova K, Froidevaux C, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001; 164: 396-402.
8. Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 2003; 31: 1737-41.
9. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007; 7: 210-7.
10. Giamarellos-Bourboulis EJ, Mega A, Grecka P, et al. Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient? Intensive Care Med 2002; 28: 1351-6.
11. Endo S, Aikawa N, Fujishima S, et al. Usefulness of procalcitonin serum level for the discrimination of severe sepsis from sepsis: a multicenter prospective study. J Infect Chemother 2008; 14: 244-9.
12. Oberholzer A, Souza SM, Tschoeke SK, et al. Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock 2005; 23: 488-93.
13. Ugarte H, Silva E, Mercan D, De Mendonça A, Vincent JL. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999; 27: 498-504.
14. Claeys R, Vinken S, Spapen H, et al. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med 2002; 30: 757-62.
15. Dahaba AA, Hagara B, Fall A, Rehak PH, List WF, Metzler H. Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis. Br J Anaesth 2006; 97: 503-8.
16. Phua J, Koay ES, Lee KH. Lactate, procalcitonin, and aminoterminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock. Shock 2008; 29: 328-33.
17. Boussekey N, Leroy O, Georges H, Devos P, d'Escrivan T, Guery B. Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit. Infection 2005; 33: 257-63.
18. Bell K, Wattie M, Byth K, et al. Procalcitonin: a marker of bacteraemia in SIRS. Anaesth Intensive Care 2003; 31: 629-36.
19. Clec'h C, Fosse JP, Karoubi P, Vincent F, Chouahi I, Hamza L, Cupa M, Cohen Y. Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med 2006; 34: 102-7.
20. Hausfater P, Juillien G, Madonna-Py B, Haroche J, Bernard M, Riou B. Serum procalcitonin measurement as diagnostic and prognostic marker in febrile adult patients presenting to the emergency department. Crit Care 2007; 11: R60.
21. Heper Y, Akalin EH, Mistik R, et al. Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock. Eur J Clin Microbiol Infect Dis 2006; 25: 481-91.
22. Pettilä V, Hynninen M, Takkunen O, Kuusela P, Valtonen M. Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis. Intensive Care Med 2002; 28: 1220-5.
23. Wunder C, Eichelbrönner O, Roewer N. Are IL-6, IL-10 and PCT plasma concentrations reliable for outcome prediction in severe sepsis? A comparison with APACHE III and SAPS II. Inflamm Res 2004; 53: 158-63.
24. Novotny A, Emmanuel K, Matevossian E, et al. Use of procalcitonin for early prediction of lethal outcome of postoperative sepsis. Am J Surg 2007; 194: 35-9.
25. Lee CC, Chen SY, Tsai CL, et al. Prognostic value of mortality in emergency department sepsis score, procalcitonin, and C-reactive protein in patients with sepsis at the emergency department. Shock 2008; 29: 322-7.
26. Viallon A, Guyomarc'h S, Marjollet O, et al. Can emergency physicians identify a high mortality subgroup of patients with sepsis: role of procalcitonin. Eur J Emerg Med 2008; 15: 26-33.
27. Loisa P, Rinne T, Laine S, Hurme M, Kaukinen S. Antiinflammatory cytokine response and the development of multiple organ failure in severe sepsis. Acta Anaesthesiol Scand 2003; 47: 319-25.
28. Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001; 286: 1754-8.
29. Tormo A, Santolaria F, González-Reimers F, et al. Short-term prognostic value of subjective nutritional assessment in general medical patients. J Nutr Med 1994; 4: 287-95.
30. Holm A, Pedersen SS, Nexoe J, et al. Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care. Br J Gen Pract 2007; 57: 555-60.
31. Stolz D, Christ-Crain M, Gencay MM, et al. Diagnostic value of signs, symptoms and laboratory values in lower respiratory tract infection. Swiss Med Wkly 2006; 136: 434-40.
32. Routsi C, Pratikaki M, Sotiropoulou C, et al. Application of the sequential organ failure assessment (SOFA) score to bacteremic ICU patients. Infection 2007; 35: 240-4.
33. Jones AE, Fiechtl JF, Brown MD, Ballew JJ, Kline JA. Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med 2007; 50: 34-41.
34. Charles PE, Ladoire S, Aho S, et al. Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria. BMC Infect Dis 2008; 26: 38.
35. Fraunberger P, Wang Y, Holler E, et al. Prognostic value of interleukin 6, procalcitonin, and C-reactive protein levels in intensive care unit patients during first increase of fever. Shock 2006; 26: 10-2.
36. Meng FS, Su L, Tang YQ, Wen Q, Liu YS, Liu ZF. Serum procalcitonin at the time of admission to the ICU as a predictor of short-term mortality. Clin Biochem 2009; 42: 1025-31.
37. Ruiz-Alvarez MJ, García-Valdecasas S, De Pablo R, et al. Diagnostic efficacy and prognostic value of serum procalcitonin concentration in patients with suspected sepsis. J Intensive Care Med 2009; 24: 63-71.
38. Gibot S, Cravoisy A, Kolopp-Sarda MN, et al. Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med 2005; 33: 792-6.
39. Burgmann H, Winkler S, Locker GJ, et al. Increased serum concentration of soluble CD14 is a prognostic marker in grampositive sepsis. Clin Immunol Immunopathol 1996; 80: 307-10.
40. Landmann R, Zimmerli W, Sansano S, et al. Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock. J Infect Dis 1995; 171: 639-44.
41. Tejera A, Santolaria F, Diez ML, et al. Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response. Cytokine 2007; 38: 117-23.
42. Gaïni S, Koldkjaer OG, Møller HJ, Pedersen C, Pedersen SS. A comparison of high-mobility group-box 1 protein, lipopolysaccharidebinding protein and procalcitonin in severe community-acquired infections and bacteraemia: a prospective study. Crit Care 2007; 11: R76.
43. Opal SM, Scannon PJ, Vincent JL, et al. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 1999; 180: 1584-9.
44. Sakr Y, Burgett U, Nacul FE, Reinhart K, Brunkhorst F. Lipopolysaccharide binding protein in a surgical intensive care unit: a marker of sepsis? Crit Care Med 2008; 36: 2014-22.
45. Maruna P, Gurlich R, Frasko R, Haluzik M. Serum leptin levels in septic men correlate well with C-reactive protein (CRP) and TNFalpha but not with BMI. Physiol Res 2001; 50: 89-94.
46. Aleman MR, Santolaria F, Batista N, et al. Leptin role in advanced lung cancer. A mediator of the acute phase response or a marker of the status of nutrition? Cytokine 2002; 19: 21-6.
47. Díez ML, Santolaria F, Tejera A, et al. Serum leptin levels in community acquired pneumonia (CAP) are related to nutritional status and not to acute phase reaction. Cytokine 2008; 42: 156-60.